mPEG-PDLLA Micelles Potentiate Docetaxel for Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Metastasis

• Egile Nagusiak: Yumei Zhang (Egilea), Shunli Wang (Egilea), Xiaofan Duan (Egilea), Xiaoxiao Xu (Egilea), Yuan Gao (Egilea), Jiuli Zhou (Egilea), Xiaolin Xu (Egilea), Jin Li (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Ovarian cancer is the second most common cause of gynecological cancer death in women. It is usually diagnosed late and accompanied by peritoneal metastasis. For ovarian cancer with peritoneal metastasis, intraperitoneal (IP) chemotherapy can maintain a high drug concentration in the abdominal cavit...